LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article: Vascular access device type for systemic anti-cancer therapies: a scoping review protocol.

    Duggan, Caitriona / Hernon, Orlaith / Dunne, Rosie / McInerney, Veronica / Walsh, Stewart R / Carr, Peter J

    British journal of nursing (Mark Allen Publishing)

    2023  Volume 32, Issue 7, Page(s) S18–S22

    Abstract: Introduction: Vascular access devices (VADs) are the most common invasive procedure performed in acute medicine and cancer patients undergo multiple invasive vascular access procedures. Our aim is to identify the type of evidence available regarding the ...

    Abstract Introduction: Vascular access devices (VADs) are the most common invasive procedure performed in acute medicine and cancer patients undergo multiple invasive vascular access procedures. Our aim is to identify the type of evidence available regarding the best choice of VAD for cancer patients undergoing systemic anti-cancer therapy (SACT). In this article, the authors frame the scoping review protocol used, which will systematically report all published and unpublished literature around the use of VADs for the infusion of SACT in oncology.
    Inclusion criteria: For studies to be included, they must focus on people or populations aged 18 years or older and report on vascular access in cancer patients. The concept is the variety of VAD use in cancer and reported insertion and post-insertion complications. The context surrounds the intravenous treatment of SACT whether in a cancer centre or non-cancer setting.
    Methods: The JBI scoping review methodology framework will guide the conduct of this scoping review. Electronic databases (CINAHL, Cochrane, Medline and Embase) will be searched. Grey literature sources and the reference lists of key studies will be reviewed to identify those appropriate for inclusion. No date limits will be used in the searches and studies will be limited to the English language. Two reviewers will independently screen all titles and abstracts and full-text studies for inclusion, and a third reviewer will arbitrate disagreements. All bibliographic data, study characteristics and indicators will be collected and charted using a data extraction tool.
    MeSH term(s) Humans ; Neoplasms/drug therapy ; Research Design ; Review Literature as Topic
    Language English
    Publishing date 2023-04-07
    Publishing country England
    Document type Journal Article
    ZDB-ID 1119191-0
    ISSN 0966-0461
    ISSN 0966-0461
    DOI 10.12968/bjon.2023.32.7.S18
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Prioritising Informed Health Choices Key Concepts for those impacted by cancer: a protocol.

    Li, Mengqi / Devane, Declan / Beecher, Claire / Duffy, Austin G / Duggan, Caitriona / Dowling, Maura / Grimes, David Robert / Kennan, Avril / McLoughlin, Sarah / Nsangi, Allen / Oxman, Andrew D / O'Connor, Robert / Stewart, Derek C / Toomey, Elaine / Tierney, Marie

    HRB open research

    2022  Volume 5, Page(s) 55

    Abstract: Background: ...

    Abstract Background:
    Language English
    Publishing date 2022-08-04
    Publishing country Ireland
    Document type Journal Article
    ISSN 2515-4826
    ISSN (online) 2515-4826
    DOI 10.12688/hrbopenres.13593.1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Oral loratadine in the management of G-CSF-induced bone pain: a pilot study.

    Duggan, Caitriona / Murphy, Louise / Costello, Vicky / Leary, Eilis O / Yousif, Ala Dien / Blazkova, Silvie / Dowling, Maura

    British journal of nursing (Mark Allen Publishing)

    2019  Volume 28, Issue 4, Page(s) S4–S11

    Abstract: This pilot study aimed to ascertain if bone pain induced by granulocyte-colony stimulating factors (G-CSFs) can be alleviated or eliminated by oral antihistamine loratadine. Twelve patients with cancer receiving chemotherapy were included in the study. ... ...

    Abstract This pilot study aimed to ascertain if bone pain induced by granulocyte-colony stimulating factors (G-CSFs) can be alleviated or eliminated by oral antihistamine loratadine. Twelve patients with cancer receiving chemotherapy were included in the study. Daily pain increased between before treatment started and after cycle 1 in all patients. All 12 participants were started on loratadine on cycle 2; three patients were taking pain medications in addition to this as needed, which were ibruprofen (n=1) or tramadol (n=2). Pain decreased towards the later cycles after patients were started on loratadine in cycle 2, with the exception of one patient who also took tramadol as needed in cycle 3. Oral loratadine was found to be associated with pain reduction in patients with cancer receiving G-CSFs.
    MeSH term(s) Administration, Oral ; Adult ; Aged ; Bone Diseases/epidemiology ; Bone Diseases/prevention & control ; Female ; Granulocyte Colony-Stimulating Factor/adverse effects ; Humans ; Loratadine/administration & dosage ; Male ; Middle Aged ; Neoplasms/drug therapy ; Pain/drug therapy ; Pilot Projects ; Treatment Outcome
    Chemical Substances Granulocyte Colony-Stimulating Factor (143011-72-7) ; Loratadine (7AJO3BO7QN)
    Language English
    Publishing date 2019-02-27
    Publishing country England
    Document type Journal Article
    ZDB-ID 1119191-0
    ISSN 0966-0461
    ISSN 0966-0461
    DOI 10.12968/bjon.2019.28.4.S4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top